AEON Biopharma (AEON)
XASE:AEON
Want to see AEON full AI Analyst Report?
Total Valuation
AEON Biopharma has a market cap or net worth of $22.49M. The enterprise value is $6.59M.
Market Cap$22.49M
Enterprise Value$6.59M
Share Statistics
AEON Biopharma has 26,307,210 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,307,210
Owned by Insiders41.30%
Owned by Institutions9.85%
Financial Efficiency
AEON Biopharma’s return on equity (ROE) is 0.71 and return on invested capital (ROIC) is 1180.00%.
Return on Equity (ROE)0.71
Return on Assets (ROA)-7.05
Return on Invested Capital (ROIC)1180.00%
Return on Capital Employed (ROCE)9.58
Revenue Per Employee0.00
Profits Per Employee-7.84M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AEON Biopharma is ―. AEON Biopharma’s PEG ratio is 0.00265.
PE Ratio―
PS Ratio0.00
PB Ratio-0.20
Price to Fair Value-0.20
Price to FCF-0.63
Price to Operating Cash Flow-0.87
PEG Ratio0.00265
Income Statement
In the last 12 months, AEON Biopharma had revenue of 0.00 and earned -39.22M in profits. Earnings per share was -3.95.
Revenue0.00
Gross Profit0.00
Operating Income-12.80M
Pretax Income-39.22M
Net Income-39.22M
EBITDA-16.22M
Earnings Per Share (EPS)-3.95
Cash Flow
In the last 12 months, operating cash flow was -12.04M and capital expenditures 0.00, giving a free cash flow of -12.04M billion.
Operating Cash Flow-12.04M
Free Cash Flow-12.04M
Free Cash Flow per Share-0.46
Dividends & Yields
AEON Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change74.49%
50-Day Moving Average0.98
200-Day Moving Average0.95
Relative Strength Index (RSI)44.79
Average Volume (3m)273.24K
Important Dates
AEON Biopharma upcoming earnings date is Aug 18, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
AEON Biopharma as a current ratio of 0.49, with Debt / Equity ratio of -15.67%
Current Ratio0.49
Quick Ratio0.49
Debt to Market Cap3.17
Net Debt to EBITDA-2.02
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AEON Biopharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AEON Biopharma EV to EBITDA ratio is -2.69, with an EV/FCF ratio of -2.52.
EV to Sales0.00
EV to EBITDA-2.69
EV to Free Cash Flow-2.52
EV to Operating Cash Flow-2.52
Balance Sheet
AEON Biopharma has $6.24M in cash and marketable securities with $2.63M in debt, giving a net cash position of $3.62M billion.
Cash & Marketable Securities$6.24M
Total Debt$2.63M
Net Cash$3.62M
Net Cash Per Share$0.14
Tangible Book Value Per Share-$5.55
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for AEON Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-101.45%